Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Astellas Pharma : Transfer of Distribution Rights for Targocid® and Maalox®

09/08/2011 | 10:10pm US/Eastern

Astellas Pharma Inc. (“Astellas Pharma”; Headquarters: Chuo-ku, Tokyo; President and CEO: Yoshihiko Hatanaka) and sanofi-aventis K.K. (“sanofi-aventis”; Headquarters: Shinjuku-ku, Tokyo; Representative Director and President: Jez Moulding) announced that Astellas Pharma will transfer the rights to distribute the injectable antibiotics Targocid® (generic name: teicoplanin) and the treatment for peptic ulcer and gastritis Maalox® (generic name: dried aluminum hydroxide gel and magnesium hydroxide) to sanofi-aventis effective on January 1, 2012. This transfer of distribution rights is taking place based on the expiration of the contract.

<Products for which distribution rights will be transferred>

Recommend :
React to this article
1d ago ASTELLAS PHARMA : Named National Presenting Sponsor of the National Kidney Found..
1d ago ASTELLAS PHARMA : Studies from Astellas Pharma, Inc. in the Area of Quality of L..
1d ago ASTELLAS PHARMA : US, Inc. reaches agreement with U.S. Department of Justice
7d ago ASTELLAS PHARMA : -Launch of Suglat Tablets, a Selective SGLT2 Inhibitor for Tre..
04/17 ASTELLAS PHARMA : US, Inc. to Pay $7.3 Million to Resolve False Claims Act Alleg..
04/16 ASTELLAS PHARMA : Launch of Suglat® Tablets, a Selective SGLT2 Inhibitor for Tre..
04/16 ASTELLAS PHARMA : Findings from Astellas Pharma, Inc. Yields New Data on HIV/AID..
04/16 ASTELLAS PHARMA : US Inc. to Pay $7.3 Million to Resolve False Claims Act Allega..
04/16 ASTELLAS PHARMA : Illinois-based Astellas to pay $7.3M settlement
04/16 ASTELLAS PHARMA : to pay $7.3M in drug-marketing settlement
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Income Statement Evolution
Astellas Pharma Inc : Income Statement Evolution
More Financials
Dynamic quotes